New Vehicle Formulations for Skin Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: 31 March 2027 | Viewed by 82
Editors
2. Elias Emergency University Hospital, Bucharest, Romania
Interests: skin healing; chronic wounds; bacterial biofilms; host–microbiome interactions; antibacterial therapies; targeted therapy; nanotechnology; skin cancer; melanoma; dermoscopy; skin aging
Special Issues, Collections and Topics in MDPI journals
Interests: dermatology; aesthetic medicine; skin aging; innovative vehicle formulations; skin microbiome; wound healing; oncodermatology; non-invasive skin imaging; nanocarrier-based drug delivery
Special Issue Information
Dear Colleagues,
Skin diseases remain a significant therapeutic challenge due to their chronicity, biological heterogeneity, altered barrier function, inflammatory complexity, and frequent need for prolonged treatment. Although numerous active pharmaceutical ingredients are available for dermatological use, their clinical performance may be limited by poor cutaneous penetration, inadequate retention within target skin layers, low bioavailability, physicochemical instability, local irritation, and suboptimal patient adherence.
This Special Issue, “New Vehicle Formulations for Skin Diseases”, aims to provide a comprehensive collection of original research articles and reviews addressing innovative formulation strategies for the prevention, management, and treatment of dermatological disorders. The topic is closely aligned with the scope of Pharmaceutics, particularly in pharmaceutical technology, topical and transdermal drug delivery, controlled-release systems, nanomedicine, biomaterials, and targeted therapeutic platforms.
We welcome contributions focusing on novel topical and transdermal vehicles, nanocarriers, liposomes, ethosomes, transfersomes, hydrogels, microemulsions, polymeric systems, microneedle-based platforms, bioadhesive formulations, antimicrobial and antibiofilm delivery systems, and regenerative or aesthetic dermatology formulations. Studies addressing inflammatory, infectious, autoimmune, oncologic, pigmentary, wound-related, and age-associated skin diseases are particularly encouraged, especially when supported by mechanistic, preclinical, translational, or clinical evidence.
Dr. Mara Mihai
Dr. Beatrice Bălăceanu-Gurău
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- topical drug delivery
- vehicle formulations
- dermatological formulations
- nanocarriers
- transdermal delivery
- controlled release
- skin barrier
- hydrogels
- nanomedicine
- skin diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
